Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinic acid plus simvastatin versus higher-dose simvastatin in carotid artery stenosis and dyslipidemia
2014-003213-29Phase 3Completed
- Sponsor
- Sciencepharma
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in carotid atheroma (CAS), dyslipidemia and atherosclerosis comparing Nicotinic acid + simvastatin 20 mg with Simvastatin 40 mg (2 arms). Primary endpoint: Change in common carotid artery intima-media thickness. Started Nov 2014; status: completed.
02
Drugs
niacinsimvastatin
03
Conditions
carotid atheroma (CAS)dyslipidemiaatherosclerosis
Beyond the preview
Go deeper on 2014-003213-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003213-29.